Judgment In Securities Class Action Against Generic Drug Maker Stands
BROOKLYN, N.Y. — A federal judge in New York on March 16 denied a motion to alter or amend his judgment dismissing federal securities law claims filed by an investor in...To view the full article, register now.
Already a subscriber? Click here to view full article